Societynationalverified · 90%

Government Owned Inventions Available for License: Establishment and Characterization of the A1847 Human Ovarian Carcinoma Line

When
· day precision
Where
United States, US
Category
government_regulation · notice

The National Cancer Institute (NCI) seeks licensees for a tumorigenic cell line, A1847, from a patient with metastatic ovarian cancer. As a BRCA1 deficient cell line, it serves as a model to researchers studying cell cycle regulation, tumor suppression and effective drugs aiding in repair of DNA damage.

Sources

Defaxon links out to the original reporting and never republishes article text.

Correlated events

Computed by the Defaxon correlation engine — linked by shared actors, co-location, and temporal proximity. Scored hypotheses, never causal claims.

← Back to the live map